438
Participants
Start Date
May 31, 2007
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
Alogliptin
Alogliptin 6.25 mg, tablets, orally, once daily for up to 40 weeks.
Alogliptin
Alogliptin 12.5 mg, tablets, orally, once daily for up to 40 weeks.
Alogliptin
Alogliptin 25 mg, tablets, orally, once daily for up to 40 weeks.
Alogliptin
Alogliptin 50 mg, tablets, orally, once daily for up to 40 weeks.
Voglibose
Voglibose 0.2 mg, tablets, orally, three times daily for up to 40 weeks.
Lead Sponsor
Takeda
INDUSTRY